FDA Clears Sonic DL™ for Cardiac MRI Scans
On June 5, 2023, GE HealthCare announced the FDA 510(k) clearance of Sonic DL™. GE HealthCare reports that Sonic DL™ is a deep learning-based technology intended to capture cardiac MRI images within a single heartbeat.
GE HealthCare states that current cardiovascular MRI systems require prolonged breath holding because several heartbeats are required to capture acceptable imaging. According to the announcement, Sonic DL™ introduces an AI deep learning-based technology into the cardiac MRI method and produces results 12 times faster than the standard procedures.
Jie Xue, President & CEO and Global MR of GE HealthCare, stated:
According to a market model by GlobalData, GE HealthCare continues to expand its AI-enabled solutions portfolio and is estimated to occupy a 25% share of the global MRI market. Another report forecasts that the global MRI market will be over $9 Billion by 2030.
The press release from GE HealthCare may be found here.